Skip to content
memantine

Structure via PubChem · Public domain (PubChem)

EntityQ412189· pop 35· linked from 2,852 articles

Also known as 3,5-dimethyl-1-adamantanamine, 1,3-dimethyl-5-adamantanamine, 3,5-dimethyl-1-aminoadamantane, 3,5-dimethyltricyclo[3.3.1.1(3,7)]decan-1-amine, 1-amino-3,5-dimethyladamantane, 1,3-dimethylaminoadamantane

Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.

Chemical data

Formula
C12H21N
Molecular weight
179.3 g/mol
IUPAC name
3,5-dimethyladamantan-1-amine
SMILES
CC12CC3CC(C1)(CC(C3)(C2)N)C
InChIKey
BUGYDGFZZOZRHP-UHFFFAOYSA-N
XLogP
3.3
Polar surface area
26 Ų
H-bond donors
1
H-bond acceptors
1
Formal charge
0

via PubChem

Described at

Memantine: a medicine to treat some types of dementia. - NHS

NHS medicines information on memantine – what it's used for, side effects, dosage and who can take it.

nhs.uk

Link to a page describing this subject · 2,355 chars · not written by Vinony

Wikidata facts

Mass
179.1674
Show 6 more facts
Commons category
Memantine
chemical formula
C₁₂H₂₁N
canonical SMILES
CC12CC3CC(C1)(CC(C3)(C2)N)C
World Health Organisation international non-proprietary name
memantine
defined daily dose
40
Sources (7)

via Wikidata · CC0

~19 min read

Article

31 sections
Contents
  • Medical uses
  • Alzheimer's disease and dementia
  • Radiation therapy
  • Adverse effects
  • Pharmacology
  • Pharmacodynamics
  • Glutamatergic
  • Serotonergic
  • Cholinergic
  • Dopaminergic
  • Sigmaergic
  • Other actions
  • Pharmacokinetics
  • Absorption
  • Distribution
  • Metabolism
  • Elimination
  • Chemistry
  • History
  • Society and culture
  • Recreational use
  • Brand names
  • Research
  • Psychiatric disorders
  • Parkinson's disease
  • Apathy
  • Long COVID
  • Catatonia
  • Autism spectrum disorder
  • References
  • Further reading

Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.

Common side effects include headache, constipation, sleepiness, and dizziness. Severe side effects may include blood clots, psychosis, and heart failure. It is believed to work by acting on NMDA receptors, working as a pore blocker of these ion channels.

Connections

Categories